These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28459956)

  • 1. Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
    Filosso PL; Guerrera F; Evangelista A; Galassi C; Welter S; Rendina EA; Travis W; Lim E; Sarkaria I; Thomas PA;
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):339-345. PubMed ID: 28459956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    Wakeam E; Adibfar A; Stokes S; Leighl NB; Giuliani ME; Varghese TK; Darling GE
    J Thorac Cardiovasc Surg; 2020 May; 159(5):2043-2054.e9. PubMed ID: 31759623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.
    Raman V; Jawitz OK; Yang CJ; Tong BC; D'Amico TA; Berry MF; Harpole DH
    Ann Thorac Surg; 2019 Aug; 108(2):377-383. PubMed ID: 31004586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
    Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
    J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical results of large cell neuroendocrine carcinoma of the lung].
    Cağirici U; Cakan A; Samancilar O; Veral A; Ozhan M
    Tuberk Toraks; 2006; 54(1):30-3. PubMed ID: 16615015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.
    Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G
    Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognosis of lung large cell neuroendocrine carcinoma.
    Jiang H; Wu Q; Zhong Y
    Bull Cancer; 2021 Oct; 108(10):981-987. PubMed ID: 34392973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.
    Filosso PL; Guerrera F; Evangelista A; Welter S; Thomas P; Casado PM; Rendina EA; Venuta F; Ampollini L; Brunelli A; Stella F; Nosotti M; Raveglia F; Larocca V; Rena O; Margaritora S; Ardissone F; Travis WD; Sarkaria I; Sagan D;
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):441-7; discussion 447. PubMed ID: 25564217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
    Komiya T; Ravindra N; Powell E
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):365-370. PubMed ID: 33639649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large cell neuroendocrine carcinoma of the ampulla of Vater.
    Beggs RE; Kelly ME; Eltayeb O; Crotty P; McDermott R; Ridgway PF
    JOP; 2012 Sep; 13(5):470-5. PubMed ID: 22964952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung.
    Dresler CM; Ritter JH; Patterson GA; Ross E; Bailey MS; Wick MR
    Ann Thorac Surg; 1997 Jan; 63(1):180-5. PubMed ID: 8993262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
    Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
    Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of the expression of drug-resistant proteins in large cell neuroendocrine carcinoma of the lung.
    Okada D; Kawamoto M; Koizumi K; Tanaka S; Fukuda Y
    Jpn J Thorac Cardiovasc Surg; 2003 Jul; 51(7):272-6. PubMed ID: 12892456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report from the European Society of Thoracic Surgeons prospective thymic database 2017: a powerful resource for a collaborative global effort to manage thymic tumours.
    Ruffini E; Guerrera F; Brunelli A; Passani S; Pellicano D; Thomas P; Van Raemdonck D; Rocco G; Venuta F; Weder W; Detterbeck F; Falcoz PE
    Eur J Cardiothorac Surg; 2019 Apr; 55(4):601-609. PubMed ID: 30649256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of adjuvant chemotherapy with irinotecan and cisplatin for completely resected high-grade pulmonary neuroendocrine carcinoma (large cell neuroendocrine carcinoma and small cell lung cancer).
    Kenmotsu H; Niho S; Ito T; Ishikawa Y; Noguchi M; Tada H; Sekine I; Watanabe S; Yoshimura M; Yamamoto N; Oshita F; Kubota K; Nagai K
    Lung Cancer; 2014 Jun; 84(3):254-8. PubMed ID: 24679951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.